Consistent with these findings, our data showed that metformin diminished HMGB1-induced MMP-2 upregulation, suggesting that metformin’s inhibitory effect extends to critical downstream molecules involved in cancer metastasis (Figure 7). The gene discussed is MMP2; the disease is cancer.